tetradecanoylphorbol acetate has been researched along with triiodothyronine, reverse in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inada, M; Masaki, H; Mori, Y; Nishikawa, M; Toyoda, N; Urakami, M; Yoshikawa, N; Yoshimura, M | 1 |
| Koenig, RJ | 1 |
2 other study(ies) available for tetradecanoylphorbol acetate and triiodothyronine, reverse
| Article | Year |
|---|---|
3,3',5'-Triiodothyronine inhibits collagen-induced human platelet aggregation.
Topics: Blood Platelets; Blood Proteins; Collagen; Humans; Phosphorylation; Platelet Aggregation; Platelet Aggregation Inhibitors; Recombinant Proteins; Serotonin; Tetradecanoylphorbol Acetate; Thrombin; Triiodothyronine; Triiodothyronine, Reverse | 1992 |
Regulation of thyroxine 5'-deiodinase by thyroid hormones and activators of protein kinase C in GH4C1 cells.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Calcimycin; Cell Line; Colforsin; Cyclic GMP; Dose-Response Relationship, Drug; Enzyme Activation; Hypothyroidism; Iodide Peroxidase; Phorbol Esters; Pituitary Neoplasms; Protein Kinase C; Rats; Tetradecanoylphorbol Acetate; Thyroid Hormones; Thyrotropin-Releasing Hormone; Thyroxine; Trifluoperazine; Triiodothyronine; Triiodothyronine, Reverse | 1986 |